[HTML][HTML] Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving …
Background Plasmodium falciparum malaria remains a major public health concern in sub-
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in …
P Sondo, MC Tahita, H Ilboudo… - Archives of public …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Plasmodium falciparum malaria remains a major public health concern in sub-
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in …
P Sondo, MC Tahita, H Ilboudo, T Rouamba… - Archives of Public …, 2022 - go.gale.com
Background Plasmodium falciparum malaria remains a major public health concern in sub-
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in …
P Sondo, MC Tahita, H Ilboudo… - Archives of Public …, 2022 - search.proquest.com
Background Plasmodium falciparum malaria remains a major public health concern in sub-
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
[HTML][HTML] Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving …
P Sondo, MC Tahita, H Ilboudo, T Rouamba… - Archives of Public …, 2022 - ncbi.nlm.nih.gov
Background Plasmodium falciparum malaria remains a major public health concern in sub-
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
[HTML][HTML] Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving …
P Sondo, MC Tahita, H Ilboudo… - Archives of …, 2022 - archpublichealth.biomedcentral.com
Plasmodium falciparum malaria remains a major public health concern in sub-Sahara Africa.
Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine-pyrimethamine …
Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine-pyrimethamine …
Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in …
P Sondo, MC Tahita, H Ilboudo… - Archives of Public …, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> Plasmodium falciparum malaria remains a
major public health concern in sub-Sahara Africa. Seasonal malaria chemoprevention …
major public health concern in sub-Sahara Africa. Seasonal malaria chemoprevention …
Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in …
P Sondo, MC Tahita, H Ilboudo, T Rouamba… - Archives of Public …, 2022 - europepmc.org
Background Plasmodium falciparum malaria remains a major public health concern in sub-
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …
Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine+ sulfadoxine …